Gujarat Terce Laboratories Limited has returned to profitability in the financial year ended 31 March 2026, reporting a net profit of ₹220.17 lakh compared to a loss of ₹97.87 lakh in the previous year. The company's board approved the annual audited standalone financial results at a meeting held on 29 May 2026. Revenue from operations for the year stood at ₹4747.27 lakh, a decrease from ₹5019.52 lakh in FY25, while total revenue was ₹4781.31 lakh.

The statutory auditor, Shah Doshi Patel & Associates LLP, issued an unmodified opinion on the financial results. The company reported an exceptional item of ₹45.39 lakh during the year, attributed to a one-time increase in provision for employee benefits due to the New Labour Codes. For the fourth quarter ended 31 March 2026, the company posted a profit after tax of ₹10.10 lakh, with revenue from operations at ₹1139.93 lakh.

The board meeting, which commenced at 3:00 p.m. and concluded at 8:31 p.m. on 29 May 2026, was conducted in compliance with Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted by Company Secretary Ashka Solanki. The company's earnings per share (EPS) for the year improved to ₹2.92 basic and diluted from a negative ₹1.32 and ₹1.26 respectively in the prior year.

Management Commentary

In an investor presentation released on 3 June 2026, the company highlighted that FY26 was a year of strengthening fundamentals and improving earnings quality. While revenue declined by 5% over FY25, the strategic focus on profitability and operational efficiency resulted in an EBITDA of ₹363 lakh. The company's net worth strengthened by over 50% during the year, supported by improved earnings and a stronger capital structure. Prudent financial discipline led to lower finance costs, improved liquidity, and positive operating cash generation.

The fourth quarter was relatively challenging, with revenue of ₹1,140 lakh and EBITDA of ₹37 lakh. However, the quarter concluded with a positive PAT, reflecting the resilience of the business and the benefits of structural improvements implemented over the past year. The company continues to focus on strengthening brand equity, improving field productivity, and maintaining financial discipline to create a stronger platform for sustainable value creation.

Gujarat Terce Laboratories Limited has amended its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information to align with the recent amendments to the SEBI (Prohibition of Insider Trading) Regulations, 2015. The revised code, effective from 29 May 2026, supersedes the earlier version and aims to ensure prompt, uniform, and adequate disclosure of information that could materially affect the price of its securities.

The company has designated its Company Secretary & Compliance Officer, Ashka Solanki, to also act as the Chief Investor Relations Officer (CIRO). The CIRO is responsible for ensuring timely dissemination of Unpublished Price Sensitive Information (UPSI) to stock exchanges, analysts, and the media to prevent selective disclosure. The code mandates that any UPSI shared with analysts or institutional investors must be made public simultaneously to maintain transparency.

Key Provisions of the Amended Code

The amended code defines UPSI to include financial results, dividends, changes in capital structure, mergers, acquisitions, key managerial personnel changes, and regulatory actions. It establishes a structured digital database to track the sharing of UPSI, ensuring that records are maintained for at least eight years. The policy also outlines conditions for sharing UPSI for "Legitimate Purposes," such as with partners, lenders, or legal advisors, provided it is done on a need-to-know basis and not to circumvent trading regulations.

Compliance and Governance

Gujarat Terce Laboratories Limited's Board of Directors adopted the revised code on 29 May 2026. The code will be reviewed annually, and any amendments to statutory or regulatory requirements will be binding immediately. The company has clarified that it is not among the top 100 or 250 listed entities by market capitalization, so its response to market rumors under Regulation 30(11) of the SEBI Listing Regulations remains voluntary.